Skip navigation
Browsing by Author Back, M.
Showing results 1 to 2 of 2
| Preview | Issue Date | Title / Name | Author(s) |
| Sep-2023 | NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma | Sim, H. W.; Wachsmuth, L.; Barnes, E. H.; Yip, S.; Koh, E. S.; Hall, M.; Jennens, R.; Ashley, D. M.; Verhaak, R. G.; Heimberger, A. B.; Rosenthal, M. A.; Hovey, E. J.; Ellingson, B. M.; Tognela, A.; Gan, H. K.; Wheeler, H.; Back, M.; McDonald, K. L.; Long, A.; Cuff, K.; Begbie, S.; Gedye, C.; Mislang, A.; Le, Hien; Johnson, M. O.; Kong, B. Y.; Simes, J. R.; Lwin, Z.; Khasraw, M.; Begbie, Stephen | |
| Jan-2006 | Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: Is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable? | Back, M.; Shakespeare, T. P.; Lim, K. H. C.; Mukherjee, R. K.; Lu, J. D.; Shakespeare, Thomas P. | |
